SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-046131
Filing Date
2009-07-31
Accepted
2009-07-31 07:00:17
Documents
7
Period of Report
2009-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a09-18461_110q.htm 10-Q 1448912
2 EX-10.1 a09-18461_1ex10d1.htm EX-10.1 50053
3 EX-12.1 a09-18461_1ex12d1.htm EX-12.1 80742
4 EX-31.1 a09-18461_1ex31d1.htm EX-31.1 14377
5 EX-31.2 a09-18461_1ex31d2.htm EX-31.2 13785
6 EX-32.1 a09-18461_1ex32d1.htm EX-32.1 6997
7 EX-32.2 a09-18461_1ex32d2.htm EX-32.2 7016
  Complete submission text file 0001104659-09-046131.txt   1623265
Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 09975309
SIC: 2834 Pharmaceutical Preparations